Britain defends Oxford vaccine roll-out among all ages amid European scepticism metro.us - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from metro.us Daily Mail and Mail on Sunday newspapers.
Britain defends Oxford-AstraZeneca vaccine rollout among all ages amid European skepticism
Britain s health minister on Wednesday defended the country s vaccine rollout strategy after skepticism emerged in Europe, saying the science supported a decision to give the shot developed by Oxford University and AstraZeneca to all age groups.
Social Sharing
Thomson Reuters ·
Pre-print study suggests longer gap between Oxford-AstraZeneca doses improves efficacy
News2 months ago
2:14Respirologist Dr. Samir Gupta talks about the latest pre-print study out of Oxford University looking at the efficacy and dose timing of its coronavirus vaccine developed with AstraZeneca.2:14
UK defends Oxford COVID-19 vaccine roll-out among all ages By Alistair Smout and Sarah Young
Britain s Health Secretary Matt Hancock holds a press briefing at Downing Street, in London
LONDON (Reuters) – Britain’s health minister defended the country’s COVID-19 vaccine roll-out strategy on Wednesday, saying the science supported a decision to give the shot developed by Oxford University and AstraZeneca to all age groups.
France, Belgium and Germany are among European Union countries to recommend that Oxford’s vaccine be given only to under 65s, and French President Emmanuel Macron was quoted on Friday as saying the shot appeared “quasi-ineffective” among those over 65.
French health body approves AstraZeneca COVID-19 vaccine By Sudip Kar-Gupta and Geert De Clercq
FILE PHOTO: Vial and sryinge are seen in front of displayed AstraZeneca logo
PARIS (Reuters) – France’s top health advisory body on Tuesday approved the use of AstraZeneca’s COVID-19 vaccine, but said the shot should only be administered to those aged under 65.
The Haute Autorite de la Sante (HAS) said people aged 50 to 65 with health issues and medical staff should get priority access.
The decision makes AstraZeneca’s vaccine the third shot available in France, after those of Pfizer/BioNTech and Moderna.
Its recommended use for those aged below 65 echoes similar advice from experts in Italy, Austria, and Germany, which said the vaccine should not be given to the elderly, citing a lack of sufficient data to recommend use in older age groups.
FILE PHOTO: A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
PARIS (Reuters) - France s top health advisory body on Tuesday approved the use of AstraZeneca s COVID-19 vaccine, but said the shot should only be administered to those aged under 65.
The Haute Autorite de la Sante (HAS) said people aged 50 to 65 with health issues and medical staff should get priority access.
The decision makes AstraZeneca s vaccine the third shot available in France, after those of Pfizer/BioNTech and Moderna.
Its recommended use for those aged below 65 echoes similar advice from experts in Italy, Austria, and Germany, which said the vaccine should not be given to the elderly, citing a lack of sufficient data to recommend use in older age groups.